Tech Company Financing Transactions
Vantage Oncology Funding Round
On 5/10/2005, Vantage Oncology raised $22 million in Series C financing from Conning Capital Partners, New Enterprise Associates and Salix Ventures.
Transaction Overview
Conning Capital Partners (Lead Investor) (Michael Aspinwall)
New Enterprise Associates (Lead Investor) (Chip Linehan)
Company Information
Mahattan Beach, CA 90266
USA
Management Team
Browse more venture capital transactions:
Prev: 5/10/2005: Novariant venture capital transaction
Next: 5/11/2005: Cellerant Therapeutics venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs